Topics
More on Mergers & Acquisitions

AmSurg buys Jandee Anesthesiology Partners, expands anesthesiology services

Company already owns 256 ambulatory surgery centers and one surgical hospital.

Beth Jones Sanborn, Managing Editor

AmSurg Headquarters-Nashville, TN. Photo by <a href="http://www.amsurg.com/"> AmSurg </a>AmSurg Headquarters-Nashville, TN. Photo by AmSurg

AmSurg Corp.'s Physician Services Division, known as Sheridan, on Wednesday said it has acquired Jandee Anesthesiology Partners and certain assets of Karadan Anesthesiology and Pain Management. Together the groups tout five anesthesiologists who deliver services through a network of nine ambulatory surgery centers as well as other facilities in New York and New Jersey.

"Jandee Anesthesiology Partners has provided excellent care to its patients for many years. After a thorough search, we selected Sheridan as the strategic partner we felt would best position us to continue our tradition of excellence," said doctors Monte Goldstein and John Pillitteri, co-managing members of Jandee Anesthesiology Partners, in a statement.

[Also: Ambulatory provider AmSurg to make public offering of common stock]

Sheridan and its affiliates provide outsourced physician services in multiple specialties to hospitals, ambulatory surgery centers and other healthcare facilities throughout the United States, primarily in the areas of anesthesiology, radiology, children's services and emergency medicine. As of March 31, 2016, AmSurg owned and operated 256 ambulatory surgery centers and one surgical hospital in 34 states and the District of Columbia, and provided physician services to more than 450 healthcare facilities in 29 states.

AmSurg has partnerships with, or employs, over 5,000 physicians and other healthcare professionals in 38 states and the District of Columbia.

[Also: UPDATED: AmSurg withdraws higher bid for TeamHealth]

The company in, early November 2015, made headlines when they pulled out of a high profile $7.6 billion deal with TeamHealth, a physician services company, that would have given shareholders 0.768 shares of AmSurg and $15.49 in cash for every share of TeamHealth. That was a raise from the original offer, which included more than $11 in cash per share of TeamHealth.

AmSurg pulled out of the deal, blaming TeamHealth board members for failing to engage with them. 

Twitter: @BethJSanborn

Show All Comments